Abbott warned on Thursday it expects more than $1 billion in financial headwinds this year from a sharp decline in COVID-19 ...

Medical device sales remained a bright spot for the company, however, with more than 20% growth in diabetes devices.

Becton Dickenson saw its Covid testing revenues tumble to $76 million in the most recent quarter, from $300 million a year earlier, and executives said they expect demand to continue to decline ...

Abbott Laboratories shares slumped Thursday after the drugmaker narrowed its full-year outlook, even as it posted better-than ...

While most people will clear the virus and get a negative antigen test result within 10 days, some people may keep testing positive for longer than that, experts tell TODAY.com. And if you keep ...

Quest's 2022 COVID-19 revenues were barely half the size of the previous year’s—and it's expecting 2023’s haul to shrink to an even smaller fraction.

The firm saw growth in its core laboratory segment but declines in molecular, point of care, and rapid diagnostics.

California skipped the Smarter Balanced assessment — which is given to all 3rd, 8th and 11th graders — statewide during two years of COVID-19. The state canceled the test in spring of 2020 ...

According to PMC officials, in May, the city reported 93 Covid cases, a significant increase after months of very low activity ...

The reasoning behind the new guidance, released on March 1st, is that COVID hospitalizations and deaths have been on the decline. The CDC attributed that to the success of “protective tools ...